The large VH3 family of human immunoglobulin genes is commonly used throughout B cell ontogeny. However, B cells ofthe fetus and certain autoantibody-producing clones are restricted to a recurrent subset of VH3 genes, and VH3 B cells are deficient in certain immunodeficiency diseases. In this study, we have sequenced a set of rearranged VH3 genes generated by genomic polymerase chain reaction (PCR) from normal adults and those with common variable immunodeficiency (CVI). In both groups, all clones were readily identifiable with the fetal VH3 subset, and were further distinguished by limited DH motifs and exclusive use ofJH4. In CVI, the residual population of VH3 B cells were notable for predominant use of 56pl-like VH genes. All clones displayed sequence divergence (including somatic mutation) with evidence of strong selection against complementarity-determining region (CDR) coding change. A survey of other V gene families indicates that human V gene diversity may be restricted in general by germline mechanisms. These findings suggest that the expressed antibody repertoire in the human adult may be much smaller than anticipated, and selected by processes in part distinct from the paradigm of maximal antigen-binding diversity. (J. Clin. Invest. 1992.
Introduction
Protective immunity depends on a highly diverse antibody repertoire. This need is met by the availability ofa large number of germline V, D, and J segments which are independently recombined, junctionally mutated, and assorted (with respect to active heavy and light chain genes) by each B cell clone. These processes provide an enormous potential repertoire of -10" antibodies (1, 2) that meets or greatly exceeds the total B cell population ofthe individual (10" and I0O for human and mouse, respectively) (3). Subsequently, each clone has the capacity for further diversification by the antigen-driven processes of variable region hypermutation in concert with strong positive biologic selection for favorable coding changes at sites contributing to antigen-binding (complementarity determining region, CDR).' In the adult mouse, the B cell pool appears to be formed by full use of these diversification mechanisms (4) (5) (6) (7) (8) (9) (10) . In humans, these mechanisms are believed to contribute to repertoire formation in a manner analogous to the mouse, based on surveys of V gene family use (1 1-14) and somatic mutation in malignant B cell clones of follicular lymphoma (15, 16) .
Paradoxically, clonal diversity during pre-B cell development and early immune ontogeny is restricted. This insight, initially established in murine studies (4) (5) (6) , has been confirmed in the human fetal to neonatal period by the predominant use of the small VkIV, VH5, and VH6 gene families, and the selective use of certain DH, VkIII, VH 1, and VH3 genes during the fetal to neonatal period (13, 14, (17) (18) (19) . For example, among the 30 members of the VH3 gene family, only 5 are abundant in fetal B cell cDNA libraries (20p1, 30p1, 38p1, 56pl, 60p2). In fact, certain highly homologous genes human VH3 and murine 7183 genes (e.g., human 30pl and murine E415; human 56pl and murine 8 1X) have a similar developmental restriction. The preferential use of these genes is presumed to reflect favored accessibility to the recombination mechanism due to factors such as chromosomal position, local cis-regulatory regions, and B cell subsets (5, 6) . It is also notable that compared to B cell clones from adults, those from early ontogeny disproportionately express autoantibodies. Some of these fetal-type clones have drawn attention due to their repetitive occurrence in B cell malignancies associated with autoreactive antibodies.
We have observed that human B cells bearing rearranged VH3 genes are selectively deficient at the germinal center stage, a critical period for antigen-driven memory differentiation (20) . Certain immunodeficiencies (HIV infection, common variable immunodeficiency [CVI] ) are associated with an overabundance of B cells phenotypically related to germinal center cells, and lymphoid populations from these individuals also display the selective depletion of VH3 B cells (21, 22) . These findings prompted us to suggest that the B cell dysfunction in these diseases may have in common a maturational arrest of B cells at the germinal center stage. A paradox raised by these studies was the cause of the physiologic VH3 B cell deficit in germinal center cells, since VH3 B cells are abundant in populations representing both germinal center cell precursors (bone marrow pre-B cells) and descendants (the recirculating pool of blood and mantle zone B cells).
One simple explanation for this paradox is that the antigendriven developmental transition occurring at the germinal center stage involves a major shift clonal pattern, including the attrition of fetal-type VH3 B cells and positive selection for other favorable VH3 B cells rare in the primary B cell population. During this transition (i.e., the germinal center stage), the net abundance ofVH3 B cells would be diminished, since restoration would only occur after the positively selected VH3 cells underwent clonal expansion (which mainly occurs after germinal center emigration). To test this explanation, we have characterized a set of rearranged VH3 genes from normal and CVI adults, with the prediction that these VH3 genes would be novel and fetal type, respectively. However, we were surprised to find that in most respects, a comparable fetal pattern was observed in both groups. Moreover, sequence divergence of these and other VH genes reflected strong selection against coding diversity. These observations raise new issues concerning the nature ofthe clonal shift during germinal center differentiation, and the mechanism of human versus murine repertoire diversification. (17, 18, (23) (24) (25) (26) (27) . The CDR3 regions were compared to a large tabulation of DH segments with respect to global homology and local homologies (> 6-7 nucleotides) using the COM-PARE, and ALIGN and SEQCOMP programs, respectively (DNA-STAR Inc., Madison, WI) (28). Calculation ofreplacement:silent(R/S) values was done manually, as described previously (29) . Nucleotide sequence data contained in this paper have been submitted to GenBank (M82924-M82936).
Methods

Results
The VH regions ofthe cloned VDJ segments are shown in Figs. 1 and 4. When compared to previously reported sequences, each clone could be readily assigned to 6 of 26 (or more [27] ) isolated VH3 germline genes. This limited occurrence of VH3 genes was not attributable to our VH3 amplimer. 19 of these germline genes are perfect matches for the VH3L amplimer sequence, and 6 differ by only 1 nt. Three clones apparently derive from the 30pl/VH26 gene, which differs from the VH3L amplimer by 1 nt. Thus, a minimum of 19, and potentially 24 or more germline VH3 genes are amplifiable by our PCR strategy. In addition, distinct categories of clones were obtained using the same amplification method from normal versus CVI groups (see below). Amplimer selection is thus unlikely to account for the observed restriction in VH3 gene cloning.
For four clones, there was some uncertainty in discerning the source germline genes among the numerous set of highly homologous 56pl-like germline genes represented by humvh3005, 1.9111, and others (27, 30) . Using six distinguishing polymorphic sites, we established that three clones (LJ33, LJ34, UJ24) were identical 56pl (versus 2 and 5 nt mismatches with 3005 and 1.91II), and one clone was identical to 1.9III (versus 4-nt mismatches for 56p1 and 3005). It is particularly notable that while these clones were common in individuals with CVI (4/6 clones and 2/3 individuals), no clones bearing 56pl-like genes were obtained from normal individuals (0/7 clones and 0/4 individuals) ( Table I) .
The CDR3 (DH and flanking N regions) of each clone is shown in Figs. 2 and 4. As usually observed for human sequences, this region is highly diverse, and in most cases not readily identifiable with known germline DH genes. Correspondence to defined DH genes was therefore assessed by computer matching for partial homologies ("motifs"), and inversions and D-D fusions which can involve DIR genes (see Discussion) . In this manner, we detected a striking use ofthe DXP family among this set ofclones: complete or partial germline D genes (in particular 21.9) were used by 8/13 clones overall, and by 8/9 non-56p/l1.9III clones (Table I ). It also appeared that the DIR-l and/or DIR-2 genes were also frequently used; in this small sample, they were limited to clones bearing 30pl/ VH26 and 56p/l1.91II VH genes ( Table I) (25) (26) (27) It therefore appeared that these divergent sequences were authentic base changes reflecting some combination ofsomatic mutations, allelic polymorphisms, and newly detected homologous genes. Their localization and effect on amino acid coding are summarized in Table III ments. However, we were surprised to also find striking suppression of R/S in the CDRs (0.91).
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We wondered whether this unusual R/S suppression of the CDRs was a unique feature of this set of VH3 genes, or a general feature ofthe VH3 or other human V gene families. Therefore, we recalculated mutation frequencies and R/S values from published sequences of several sets of V genes (Table III) In fact, CDR R/S values were remarkably low among human VH3 and VH4 genes (Table III) ; similar low values were also observed when we recalculated in intrafamily comparisons for VkIII (35, 36) and VX (37) germline genes (data not shown). These findings with human V genes were in striking contrast to mouse germline V genes (both coding and pseudogenes) (38, 29) , for which CDR R/S values were elevated substantially above neutral (R/S 7).
Discussion
To our knowledge, this study is the first sequence characterization of an unselected set of rearranged VH genes in the human adult. We had anticipated robust diversity among these clones, since they were drawn from the adult recirculating B cell population, and should be predominantly composed of relatively long-lived postantigenic B cells. However, several features of these clones systematically limited coding diversity in these clones, suggesting a global restriction in the diversity of the adult human antibody repertoire. Characterization of V, D, and J segments. All except the earliest fetal B cell populations include a major component (> 50%) ofcells expressing VH3 genes. Despite the existence of a large number ofVH3 genes, we were surprised to find only six VH3 genes in this set of rearranged VH3 clones from the adult. The recurrence of these VH3 genes does not appear to be artifactual: each clone is clearly independent based on sequence features, and by the apparent suitability of the FRI VH3 amplimer to prime at least 24/26 known germline VH3 sequences. It is striking that five of these genes (when 56p1 and 1 .9111 are considered together) correspond to the set of VH3 genes comprising the fetal B cell population and the recurrent set ofVH3 autoantibodies and neoplastic CLL/WM B cells. The one exception was LJ68, corresponding to the 2-3 pseudogene. However, previous studies have been limited to cDNA libraries or characterization of expressed antibodies, which by design exclude nonproductive VDJ rearrangement. Thus, fetal VH3 genes may actually be the only VH3 genes commonly used in the human antibody repertoire. In the future, it will be important to confirm this unexpected conclusion through additional methodologies in larger series of subjects.
In this regard, the VH4 family (consisting of 12-15 genes and only one pseudogene) is notable, since only three-four members have been found expressed (39 S-26---SC A -2---2 PS-
N regions. This complexity was manifested by the current set of clones. In addition, certain DH genes recurred among these VH13 clones, including the DXP family (especially the 21.9 gene) and DIR-like genes. The use of JH segments was also remarkably limited to JH4, even though the JH amplimer was completely homologous to JH 1, JH4, and JH5, and despite the fact that rearranged VDJ segments with JH5 have been cloned in our lab using the same PCR methodology. JH2, JH3, and JH6 were not evaluable in the present study due to amplimer design (insufficient homology). In other studies, JH 1 has been rarely observed, and the relative frequency of JH14 to JH5 appears to increase during ontogeny (2, 17, 18, 33, 34, 41) . Distinct characteristics of VH3 clones from CVI B cells. Clones obtained from subjects with CVI were unusual in their use of VH and DH segments. 56p 1-like VH genes were commonly used (4/6 clones), whereas they were absent among the clones from normal individuals (0/7 clones). For DH segments, DIR motifs were common (4/6 clones) and DXP rare (1/6 clones) in CVI, whereas the reciprocal was true for normal subjects (2/7 and 7/7 clones, respectively). Even in this small data set, a paired, two-tailed t test of these comparisons indicates that the difference between normal and CVI clones is statistically significant for 56p 1-like genes and DXP (P = 0.025 and 0.004, respectively). The predominance of 56p 1-like genes in CVI B cells is comparable with the common use of 56p1I in fetal B cells (18) , and the reported 1 I0-fold increased abundance of the corresponding B6 idiotope in fetal versus adult B cells (14) .
Since the B cell dysfunction in CVI and HIV infection share common features, it is interesting to consider the recent sequence data for VH3 cDNA clones from HIV-positive individuals reported by Marks et al. (2) . Of Despite a substantial mutation frequency, we were surprised to find that the CDR R/S values were strikingly low. Upon reanalysis of published sequences, we found that this feature was shared by all families of human germline V genes (see Results). It is also notable that very low R/S values were found for mutations observed in rearranged V gene segments associated with monospecific rheumatoid factors (48) , and clonal siblings of a non-Hodgkin's lymphoma (49) . This observation is in distinct contrast to murine V genes, which show a preference of CDR coding diversity at both the germline and somatic level. However, a population-based sequence study has just appeared (50) which reveals much greater restriction in expressed murine V genes than previously appreciated from the existing literature of V family hybridization analysis.
The biologic selection behind this limited coding diversity in human V genes is uncertain. At the germline level, it could reflect the benefit of focusing the antibody repertoire on a set of critical specificities, such as certain environmental pathogens or regulatory idiotypes (18, 29, 51) . The notion of Ig clans has also been introduced to account for phylogenetically conserved FRl segments (52, 53) bearing highly conserved binding sites for unconventional antibody-ligand interactions such as FR1-dependent rheumatoid factor activity and reactivity with Staphylococcus aureus protein A (54) (55) (56) . In fact, rheumatoid factor B cells have been directly shown to efficiently present immune complexes and elicit fully reciprocal T-B interactions (57) . These selection factors presumably contribute to the limited diversity observed at the somatic level, as also suggested in the recent murine study by Gu et al. (50) .
A global restriction of human antibody diversity. The expressed antibody repertoire is thought to be limited primarily by the size ofthe B cell pool, due to the presumption ofa largely random V/D/J recombination, assortment of light chain and heavy chain molecules, and somatic mutation. However, the present paper suggests that the expressed repertoire in the recirculating adult B cell pool is much more restricted: 4/25 VH3 genes, 5/30 DH genes, and 1/3 JH genes. Moreover, coding diversity among germline VH3 genes (by comparing CDR R/S ratios) is 1/6 that of murine VH genes, as is the diversity produced by somatic mutation. Hence, the expressed diversity in the VH3 B cell pool may only be 0.03% ofthat estimated using the paradigm of maximal diversity. In view of the low CDR R/S values for germline genes ofthe other VH and VL families, these factors for limited diversity probably hold true for the entire human antibody repertoire.
In this light, how can one account for the satisfactory state of human antibody immunity? First, the total B cell pool in humans is large (> 10"), and since the R/S values is greater than zero, the total antibody diversity is substantial. Second, the exceptional CDRIII diversity in humans may compensate for the low VH and JH diversity. Third, highly diversified populations of human B cells (for V/D/J use and high CDR R/S values) have been detected in contexts of apparent antigenic stimulation (58) , and in the follicular center cell class of B cell neoplasms (15, 16, 45) . However, the relative abundance of such B cells is uncertain, and perhaps small, considering the current study and most other reports of rearranged VH genes. If so, this would be the opposite of adult murine B cell populations in which diversified B cells are predominant. A fundamental issue to resolve will be the relative abundance of these restricted versus diversified B cell populations.
